These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36144727)

  • 1. Design, Synthesis and Structure-Activity Relationships of Phenylalanine-Containing Peptidomimetics as Novel HIV-1 Capsid Binders Based on Ugi Four-Component Reaction.
    Ji X; Li J; Sharma PP; Jiang X; Rathi B; Gao Z; Hu L; Kang D; De Clercq E; Cocklin S; Liu C; Pannecouque C; Dick A; Liu X; Zhan P
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitors.
    Li J; Jiang X; Dick A; Prakash Sharma P; Chen CH; Rathi B; Kang D; Wang Z; Ji X; Lee KH; Cocklin S; Liu X; Zhan P
    Bioorg Med Chem; 2021 Oct; 48():116414. PubMed ID: 34562701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library.
    Wu G; Zalloum WA; Meuser ME; Jing L; Kang D; Chen CH; Tian Y; Zhang F; Cocklin S; Lee KH; Liu X; Zhan P
    Eur J Med Chem; 2018 Oct; 158():478-492. PubMed ID: 30243152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.
    Zhang X; Sun L; Meuser ME; Zalloum WA; Xu S; Huang T; Cherukupalli S; Jiang X; Ding X; Tao Y; Kang D; De Clercq E; Pannecouque C; Dick A; Cocklin S; Liu X; Zhan P
    Eur J Med Chem; 2021 Dec; 226():113848. PubMed ID: 34592608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel 1,2,4-triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein.
    Jiang X; Sharma PP; Rathi B; Ji X; Hu L; Gao Z; Kang D; Wang Z; Xie M; Xu S; Zhang X; De Clercq E; Cocklin S; Pannecouque C; Dick A; Liu X; Zhan P
    J Med Virol; 2022 Dec; 94(12):5975-5986. PubMed ID: 35949003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
    Sun L; Huang T; Dick A; Meuser ME; Zalloum WA; Chen CH; Ding X; Gao P; Cocklin S; Lee KH; Zhan P; Liu X
    Eur J Med Chem; 2020 Mar; 190():112085. PubMed ID: 32066010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators.
    Zhang X; Sun L; Xu S; Shao X; Li Z; Ding D; Jiang X; Zhao S; Cocklin S; Clercq E; Pannecouque C; Dick A; Liu X; Zhan P
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators.
    Xu S; Sun L; Zalloum WA; Huang T; Zhang X; Ding D; Shao X; Jiang X; Zhao F; Cocklin S; De Clercq E; Pannecouque C; Dick A; Liu X; Zhan P
    Molecules; 2022 Dec; 27(23):. PubMed ID: 36500508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.
    Sun L; Dick A; Meuser ME; Huang T; Zalloum WA; Chen CH; Cherukupalli S; Xu S; Ding X; Gao P; Kang D; De Clercq E; Pannecouque C; Cocklin S; Lee KH; Liu X; Zhan P
    J Med Chem; 2020 May; 63(9):4790-4810. PubMed ID: 32298111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors.
    Jiang X; Wu G; Zalloum WA; Meuser ME; Dick A; Sun L; Chen CH; Kang D; Jing L; Jia R; Cocklin S; Lee KH; Liu X; Zhan P
    RSC Adv; 2019; 9(50):28961-28986. PubMed ID: 32089839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
    Yang J; Chen W; Kang D; Lu X; Li X; Liu Z; Huang B; Daelemans D; Pannecouque C; De Clercq E; Zhan P; Liu X
    Eur J Med Chem; 2016 Feb; 109():294-304. PubMed ID: 26802545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
    Xu S; Sun L; Dick A; Zalloum WA; Huang T; Meuser ME; Zhang X; Tao Y; Cherukupalli S; Ding D; Ding X; Gao S; Jiang X; Kang D; De Clercq E; Pannecouque C; Cocklin S; Liu X; Zhan P
    Eur J Med Chem; 2022 Jan; 227():113903. PubMed ID: 34653770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a small molecule HIV-1 inhibitor that targets the capsid hexamer.
    Xu JP; Branson JD; Lawrence R; Cocklin S
    Bioorg Med Chem Lett; 2016 Feb; 26(3):824-828. PubMed ID: 26747394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features.
    Gao S; Cheng Y; Song S; Song L; Zhao F; Xu S; Kang D; Sun L; Gao P; De Clercq E; Pannecouque C; Liu X; Zhan P
    Eur J Med Chem; 2022 Aug; 238():114471. PubMed ID: 35640327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus.
    Zhou Z; Liu T; Wu G; Kang D; Fu Z; Wang Z; De Clercq E; Pannecouque C; Zhan P; Liu X
    Org Biomol Chem; 2019 Mar; 17(12):3202-3217. PubMed ID: 30839042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs.
    Rai D; Chen W; Tian Y; Chen X; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
    Bioorg Med Chem; 2013 Dec; 21(23):7398-405. PubMed ID: 24134904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel HIV-1 capsid-targeting small molecules of the PF74 binding site.
    Wang L; Casey MC; Vernekar SKV; Sahani RL; Kankanala J; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Eur J Med Chem; 2020 Oct; 204():112626. PubMed ID: 32814250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Bedwell GJ; Engelman AN; Zheng YT; Chang S
    Antiviral Res; 2019 Sep; 169():104544. PubMed ID: 31254557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
    Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
    PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Characterization of HIV-1 CA-Targeting Small Molecules: Conformational Restriction of PF74.
    Sahani RL; Diana-Rivero R; Vernekar SKV; Wang L; Du H; Zhang H; Castaner AE; Casey MC; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.